In 2010, in the salinity treatment a minor QTL (6% PVE) for HI was identified on CaLG04d while in the control treatment two major QTLs for HI were identified, one each on CaLG05 (46% PVE) and CaLG08 (10% PVE).
Five QTLs were identified, one each on chromosomes 1, 3 and 7, and two on chromosome 9, explaining from 18 to 34%% of the phenotypic variation.
For panicle length two minor QTLs were identified one each on chromosome 2 (qPL2.1) and chromosome 6 (qPL6.1).
A total of three QTLs influencing chaffy grains designated as qCG3.1, qCG9.1, and qCG12.1 were identified one each on chromosomes 1, 9 and 12, respectively.
At least one CO was identified on each chromosome, with an average of 10.1 COs per meiosis.
The overall detection rate was calculated by the number of procedures in which at least one SLN was identified, divided by the total number of procedures performed, and the bilateral detection rate was calculated by the number of procedures in which at least one SLN was identified on each side of the pelvis, divided by the total number of procedures performed.
In 2011, one major QTL in the salinity treatment that explained 12% PVE was also identified on CaLG05, while one major QTL (16% PVE) and one minor QTL (8% PVE) were identified on each of CaLG05 and CaLG07 in the control treatment.
Twenty-one reproducible facial landmarks (x, y, z co-ordinates) were identified on each facial scan.
Soft tissue landmarks, which were identified on each photograph, were compared through superimposition to determine differences.
The occlusal plane was identified on each 3D rendering and used as a plane of reference.
